Drug class
Antifilarial anthelmintic; piperazine derivative
Mechanism of action
Alters microfilarial surface membrane and neuromuscular function, enhancing host immune clearance of filarial parasites. It also has activity against adult worms depending on species and regimen.
General use cases
- Treatment of lymphatic filariasis caused by susceptible Wuchereria bancrofti or Brugia species
- Treatment of loiasis caused by Loa loa and selected other filarial infections under specialist guidance; dosing requires species identification and assessment of microfilarial burden
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
